Thoracent

Minimally invasive devices for managing pleural effusions, restoring airway patency, and improving quality of life, along with an expanded suite of GI tools.

Learn more about Thoracent

Diagnostics

Developing molecular diagnostics to triage patients and ensure they get fast and effective care when they need it.

Learn more about Diagnostics

Biopsy Tools

Developing a suite of steerable endobronchial instruments to target difficult-to-reach off-airway nodules.

Learn more about our Biopsy Tools

Leadership

Maverix leadership combines decades of clinical, technical, and operating experience.

Learn more about our leadership

Advisors

The Maverix Medical Advisory Board is comprised of leading pulmonary physicians.

Meet our advisors

Partners

Maverix collaborates with firms that are transforming medtech innovation.

See our partners
Most Recent Article
Fierce Biotech
March 29, 2024

Lung Cancer Startup Maverix Medical Snaps Up Diagnostic Developer Cirrus Bio

Read More
PR Newswire
March 29, 2024
Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer
Read More
Wall Street Journal
November 30, 2023
Startup Ajax Health Extends Medtech Innovation Model to Hologic
Read More

Thoracent

Sales Inquiries
Customer Care
(888) 978-0232

About

The Thoracent stent portfolio offers supportive scaffolds for the airways and GI tract to alleviate symptoms from obstruction—providing relief and improved quality of life when it matters most.

Thoracent biopsy devices support early and accurate diagnosis.

Products

Minimally invasive tools critical to the interventional pulmonology and gastrointestinal procedure suites that improve the safety and efficacy of palliative interventions and tissue sampling.